Tuesday, November 20, 2007

Just a heads-up about this Friday's episode of Numb3rs

Just a heads-up about this Friday's episode of Numb3rs: part of the action is set at a comic convention; the comics are real, and so are some of the comics creators on the show.

Newsarama.com has a write-up about it. The creators are all indie-type
guys, so the show didn't have to jump through multiple hoops to get permissions from companies such as Marvel and DC. In the article I read, at least one of the creators actually sold quite a few of his books to cast and crew members.

Also, guest star Wil Wheaton is apparently really a comics fan; he was reading WE3 on set.

Trek's "Sarek" is Cast

Ben Cross has been cast as Sarek, the Vulcan father of Spock, in J.J. Abrams' upcoming Star Trek feature film, StarTrek.com reported.

He will be paired with Winona Ryder, portraying Spock's human mother, Amanda Grayson. (Variety had earlier incorrectly reported that Ryder would play a Vulcan.) The young Spock will be played by Zachary Quinto (Heroes 'Syler').

Sarek was first played by Mark Lenard in the original series and subsequent movies.

The film, currently in production under the direction of J.J. Abrams, is scheduled for release on Christmas Day 2008.

Monday, November 19, 2007

Half-Blood Cast Complete!!

Warner Bros. has announced that casting has been finalized for Harry Potter and the Half-Blood Prince, with the studio bringing aboard a handful of new, key characters, including the young Voldemort, Lavender Brown and Professor Slughorn.

The sixth and penultimate movie in the blockbuster franchise based on J.K. Rowling's acclaimed fantasy series has already begun shooting at the U.K.'s Leavesden Studios, with the the usual suspects—Daniel Radcliffe, Rupert Grint and Emma Watson—back on their respective broomsticks as Harry Potter, Ron Weasley and Hermione Granger.

This time around, some fresh faces have been added to the all-British company, led by Oscar-winning actor Jim Broadbent (Moulin Rouge, Iris, Indiana Jones and the Kingdom of the Crystal Skull) as new Professor of Potions Horace Slughorn.
Stepping into the part of the prebuescent Lord Voldemort, back when he was just Tom Riddle, will be nine-year-old Hero Fiennes Tiffin. The youngster will bring a real-life resemblance, as he just so happens to be the nephew of Ralph Fiennes, who plays the adult version of He-Who-Must-Not-Be-Named.

Essaying Voldemort as a mischievous teenager will be 16-year-old Frank Dillane. Helen McCrory (The Queen, Becoming Jane) has signed on to play Narcissa Black Malfoy, the mother of Harry's nemesis, Draco Malfoy.
And much to the chagrin of thousands of aspiring actresses who turned out to audition, the role of Ron's love interest, Lavender Brown, went to 20-year-old actress Jessie Cave.

Helena Bonham Carter, who made her debut as nefarious Death Eater Bellatrix Black Lestrange in last summer's Harry Potter and the Order of the Phoenix, will cast more of those deliciously evil glances Harry's way.
Also back are Potter regulars Alan Rickman (Snape), Maggie Smith (McGonagall); Michael Gambon (Dumbledore), Robbie Coltrane (Hagrid), Warwick Davis (Flitwick), David Thewlis (Lupin), David Bradley (Filch), Tom Felton (Draco Malfoy); Natalia Tena (Nymphadora Tonks), Julie Walters (Mrs. Weasley); Evanna Lynch (Luna Lovegood), Matthew Lewis (Neville Longbottom) and Bonnie Wright (Ginny Weasley).

Director David Yates, who helmed Phoenix, is back behind the camera for Half-Blood Prince, while veteran scribe Steve Kloves, who adapted the first four Harry Potter movies, returns to adapt the latest installment.

Half-Blood Prince chronicles the teen magician's sixth year at Hogwarts School for Witchcraft and Wizardry. He teams with Professor Dumbledore to journey into Voldemort's past for clues to defeat the dark lord. Along the way, Professor Slughorn gives Harry a textbook once owned by the mysterious Half-Blood Prince that helps the hero out of some sticky situations. All the action leads to a heart-wrenching confrontation.

"I am really excited that David Yates and all our cast are back for the sixth film and welcome some wonderful new additions to our ensemble," Jeff Robinov, Warner's president of production, said in a statement. "We all share a commitment to Jo Rowling and to Harry Potter fans around the world to keep making these films the best they can be and, as we head into the final installments, I can promise that this level of commitment will not waver."

Harry Potter and the Half-Blood Prince is due in theaters Nov. 21, 2008.

Wednesday, November 14, 2007

New Re-telling of "The Andromeda Strain" Coming

Andre Braugher, who stars in A&E's upcoming miniseries The Andromeda Strain, told SCI FI Wire that it will completely rework the Michael Crichton novel on which it is based.

"Crichton's book doesn't hold up to the test of time," Braugher said of the book, which was previously adapted as a movie in 1971. "And so not much happens when you go back to 1968 and you read that book. It's anticlimactic, period. So this is an entire ... retelling of the story, with the same premise, but an entirely different retelling."

Braugher co-stars alongside Benjamin Bratt, Christa Miller, Eric McCormack and Rick Schroder.

"I play a military man," Braugher said in an interview while promoting The Mist. "He's the head of the division that's supposed to be taking on this Andromeda Strain, this virus that's taking over [after a U.S. government satellite crash-lands in Utah]. Benjamin Bratt plays the mecurial, hot-headed scientist who's responsible for tracking this thing down and destroying it."

Braugher added: "The virus ultimately proves deadly. The virus escapes, and it mutates, and it's on the loose. And we have to discover a response to it. There are elements of that film Sphere [which was also based on a Crichton book], ... in terms of the involvement of another power in the creation of the virus. But ultimately it just updates it, you know? It just brings it to a present-day realm where, instead of there being this wonderful deus ex machina where the virus just mysteriously happens to become benign, now it's not mysteriously benign. It's still malignant, and it's on the loose." The Andromeda Strain will premiere in early 2008. —Ian Spelling

"I hope they don't mess it up, I quite liked the original".